BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alcayaga-Miranda F, Cuenca J, Khoury M. Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies. Front Immunol 2017;8:339. [PMID: 28424688 DOI: 10.3389/fimmu.2017.00339] [Cited by in Crossref: 94] [Cited by in F6Publishing: 116] [Article Influence: 18.8] [Reference Citation Analysis]
Number Citing Articles
1 Sheikh BA, Bhat BA, Mir MA. Antimicrobial resistance: new insights and therapeutic implications. Appl Microbiol Biotechnol 2022. [PMID: 36121484 DOI: 10.1007/s00253-022-12175-8] [Reference Citation Analysis]
2 Yang F, Ni B, Liu Q, He F, Li L, Zhong X, Zheng X, Lu J, Chen X, Lin H, Xu R, He Y, Zhang Q, Zou X, Chen W. Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota. Stem Cell Res Ther 2022;13. [DOI: 10.1186/s13287-022-03118-1] [Reference Citation Analysis]
3 Li J, Wen Q, Gu F, An L, Yu T. Non-antibiotic strategies for prevention and treatment of internalized Staphylococcus aureus. Front Microbiol 2022;13:974984. [DOI: 10.3389/fmicb.2022.974984] [Reference Citation Analysis]
4 Daniel M, Bedoui Y, Vagner D, Raffray L, Ah-pine F, Doray B, Gasque P. Pathophysiology of Sepsis and Genesis of Septic Shock: The Critical Role of Mesenchymal Stem Cells (MSCs). IJMS 2022;23:9274. [DOI: 10.3390/ijms23169274] [Reference Citation Analysis]
5 Eiro N, Fraile M, González-jubete A, González LO, Vizoso FJ. Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges. IJMS 2022;23:8905. [DOI: 10.3390/ijms23168905] [Reference Citation Analysis]
6 Moeinabadi-Bidgoli K, Rezaee M, Rismanchi H, Mohammadi MM, Babajani A. Mesenchymal Stem Cell-Derived Antimicrobial Peptides as Potential Anti-Neoplastic Agents: New Insight into Anticancer Mechanisms of Stem Cells and Exosomes. Front Cell Dev Biol 2022;10:900418. [PMID: 35874827 DOI: 10.3389/fcell.2022.900418] [Reference Citation Analysis]
7 Ghai S, Saini S, Ansari S, Verma V, Chopra S, Sharma V, Devi P, Malakar D. Allogenic umbilical cord blood-mesenchymal stem cells are more effective than antibiotics in alleviating subclinical mastitis in dairy cows. Theriogenology 2022;187:141-51. [DOI: 10.1016/j.theriogenology.2022.05.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kakabadze Z, Kipshidze N, Paresishvili T, Kipshidze N, Vadachkoria Z, Chakhunashvili D. Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat. Stem Cells Int 2022;2022:8418509. [PMID: 35756754 DOI: 10.1155/2022/8418509] [Reference Citation Analysis]
9 Johnson V, Chow L, Harrison J, Soontararak S, Dow S. Activated Mesenchymal Stromal Cell Therapy for Treatment of Multi-Drug Resistant Bacterial Infections in Dogs. Front Vet Sci 2022;9:925701. [DOI: 10.3389/fvets.2022.925701] [Reference Citation Analysis]
10 Huang J, Cui L, Natarajan M, Barone PW, Wolfrum JM, Lee YH, Rice SA, Springs SL. The ratio of nicotinic acid to nicotinamide as a microbial biomarker for assessing cell therapy product sterility. Mol Ther Methods Clin Dev 2022;25:410-24. [PMID: 35573051 DOI: 10.1016/j.omtm.2022.04.006] [Reference Citation Analysis]
11 Ahn B, Jeon H, Cho HS, Nagasundarapandian S, Park C. Sequence polymorphisms of PR39 cathelicidins and extensive copy variations in commercial pig breeds. Gene 2022;822:146323. [PMID: 35181502 DOI: 10.1016/j.gene.2022.146323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jing W, Wang H, Zhan L, Yan W. Extracellular Vesicles, New Players in Sepsis and Acute Respiratory Distress Syndrome. Front Cell Infect Microbiol 2022;12:853840. [DOI: 10.3389/fcimb.2022.853840] [Reference Citation Analysis]
13 Yao W, Shi L, Zhang Y, Dong H, Zhang Y. Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives. Stem Cell Res Ther 2022;13:124. [PMID: 35321737 DOI: 10.1186/s13287-022-02810-6] [Reference Citation Analysis]
14 Rebelatto CLK, Senegaglia AC, Franck CL, Daga DR, Shigunov P, Stimamiglio MA, Marsaro DB, Schaidt B, Micosky A, de Azambuja AP, Leitão CA, Petterle RR, Jamur VR, Vaz IM, Mallmann AP, Carraro Junior H, Ditzel E, Brofman PRS, Correa A. Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial. Stem Cell Res Ther 2022;13:122. [PMID: 35313959 DOI: 10.1186/s13287-022-02796-1] [Reference Citation Analysis]
15 Keshtkar S, Kaviani M, Soleimanian S, Azarpira N, Asvar Z, Pakbaz S. Stem Cell-Derived Exosome as Potential Therapeutics for Microbial Diseases. Front Microbiol 2021;12:786111. [PMID: 35237239 DOI: 10.3389/fmicb.2021.786111] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Robo I, Heta S, Papakozma D, Ostreni V. Modification of implant surfaces to stimulate mesenchymal cell activation. Bull Natl Res Cent 2022;46. [DOI: 10.1186/s42269-022-00743-x] [Reference Citation Analysis]
17 Krawczenko A, Klimczak A. Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells and Their Contribution to Angiogenic Processes in Tissue Regeneration. Int J Mol Sci 2022;23:2425. [PMID: 35269568 DOI: 10.3390/ijms23052425] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Hirakawa MP, Tjahjono N, Light YK, Celebi AN, Celebi NN, Chintalapudi P, Butler KS, Branda SS, Krishnakumar R. Upregulation of CD14 in mesenchymal stromal cells accelerates lipopolysaccharide-induced response and enhances antibacterial properties. iScience 2022;25:103759. [PMID: 35141503 DOI: 10.1016/j.isci.2022.103759] [Reference Citation Analysis]
19 Alvites R, Branquinho M, Sousa AC, Lopes B, Sousa P, Maurício AC. Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential. Pharmaceutics 2022;14:381. [DOI: 10.3390/pharmaceutics14020381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Izadi M, Dehghan Marvast L, Rezvani ME, Zohrabi M, Aliabadi A, Mousavi SA, Aflatoonian B. Mesenchymal Stem-Cell Derived Exosome Therapy as a Potential Future Approach for Treatment of Male Infertility Caused by Chlamydia Infection. Front Microbiol 2021;12:785622. [PMID: 35095800 DOI: 10.3389/fmicb.2021.785622] [Reference Citation Analysis]
21 Wu X, Jin S, Ding C, Wang Y, He D, Liu Y. Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed. Front Microbiol 2021;12:804813. [PMID: 35046923 DOI: 10.3389/fmicb.2021.804813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Andrukhov O, Blufstein A, Behm C. A Review of Antimicrobial Activity of Dental Mesenchymal Stromal Cells: Is There Any Potential? Front Oral Health 2022;2:832976. [DOI: 10.3389/froh.2021.832976] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Pourgholaminejad A, Pahlavanneshan S, Basiri M. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges. Scand J Immunol 2021;:e13131. [PMID: 34936112 DOI: 10.1111/sji.13131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
24 Keshavarz Alikhani H, Shokoohian B, Rezasoltani S, Hossein-Khannazer N, Yadegar A, Hassan M, Vosough M. Application of Stem Cell-Derived Extracellular Vesicles as an Innovative Theranostics in Microbial Diseases. Front Microbiol 2021;12:785856. [PMID: 34917064 DOI: 10.3389/fmicb.2021.785856] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Kudinov VA, Artyushev RI, Zurina IM, Lapshin RD, Snopova LB, Mukhina IV, Grinakovskaya OS, Saburina IN. Antimicrobial and Regenerative Effects of Placental Multipotent Mesenchymal Stromal Cell Secretome-Based Chitosan Gel on Infected Burns in Rats. Pharmaceuticals 2021;14:1263. [DOI: 10.3390/ph14121263] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Costela Ruiz VJ, Melguizo Rodríguez L, Illescas Montes R, García Recio E, Arias Santiago S, Ruiz C, De Luna Bertos E. Human adipose tissue-derived mesenchymal stromal cells and their phagocytic capacity. J Cell Mol Med 2021. [PMID: 34854223 DOI: 10.1111/jcmm.17070] [Reference Citation Analysis]
27 Kraskiewicz H, Hinc P, Krawczenko A, Bielawska-Pohl A, Paprocka M, Witkowska D, Mohd Isa IL, Pandit A, Klimczak A. HATMSC Secreted Factors in the Hydrogel as a Potential Treatment for Chronic Wounds-In Vitro Study. Int J Mol Sci 2021;22:12241. [PMID: 34830121 DOI: 10.3390/ijms222212241] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
28 Bahroudi M, Bakhshi B, Soudi S, Najar-Peerayeh S. Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate. Stem Cell Res Ther 2021;12:564. [PMID: 34732259 DOI: 10.1186/s13287-021-02622-0] [Reference Citation Analysis]
29 Masterson C, Gonzalez H, Laffey JG. Understanding the impact of the lung microenvironment to enhance the therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome. Eur Respir J 2021;58:2100986. [PMID: 34649970 DOI: 10.1183/13993003.00986-2021] [Reference Citation Analysis]
30 Shaw TD, Krasnodembskaya AD, Schroeder GN, Zumla A, Maeurer M, O'Kane CM. Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases. Clin Microbiol Rev 2021;:e0006421. [PMID: 34612662 DOI: 10.1128/CMR.00064-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Rasouli M, Rahimi A, Soleimani M, Keshel SH. The interplay between extracellular matrix and progenitor/stem cells during wound healing: Opportunities and future directions. Acta Histochem 2021;123:151785. [PMID: 34500185 DOI: 10.1016/j.acthis.2021.151785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Primorac D, Čemerin M, Matišić V, Molnar V, Strbad M, Girandon L, Zenić L, Knežević M, Minger S, Polančec D. Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics 2021;13:1481. [PMID: 34575557 DOI: 10.3390/pharmaceutics13091481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Shekarchi S, Roushandeh AM, Roudkenar MH, Bahadori MH. Dimethyl fumarate prevents cytotoxicity and apoptosis mediated by oxidative stress in human adipose-derived mesenchymal stem cells. Mol Biol Rep 2021;48:6375-85. [PMID: 34426902 DOI: 10.1007/s11033-021-06638-w] [Reference Citation Analysis]
34 Mosquera-Heredia MI, Morales LC, Vidal OM, Barceló E, Silvera-Redondo C, Vélez JI, Garavito-Galofre P. Exosomes: Potential Disease Biomarkers and New Therapeutic Targets. Biomedicines 2021;9:1061. [PMID: 34440265 DOI: 10.3390/biomedicines9081061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
35 Raghav A, Tripathi P, Mishra BK, Jeong GB, Banday S, Gautam KA, Mateen QN, Singh P, Singh M, Singla A, Ahmad J. Mesenchymal Stromal Cell-Derived Tailored Exosomes Treat Bacteria-Associated Diabetes Foot Ulcers: A Customized Approach From Bench to Bed. Front Microbiol 2021;12:712588. [PMID: 34385994 DOI: 10.3389/fmicb.2021.712588] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
36 Scutera S, Mitola S, Sparti R, Salvi V, Grillo E, Piersigilli G, Bugatti M, Alotto D, Schioppa T, Sozzani S, Musso T. Bartonella henselae Persistence within Mesenchymal Stromal Cells Enhances Endothelial Cell Activation and Infectibility That Amplifies the Angiogenic Process. Infect Immun 2021;89:e0014121. [PMID: 34031126 DOI: 10.1128/IAI.00141-21] [Reference Citation Analysis]
37 Laneri S, Brancaccio M, Mennitti C, De Biasi MG, Pero ME, Pisanelli G, Scudiero O, Pero R. Antimicrobial Peptides and Physical Activity: A Great Hope against COVID 19. Microorganisms 2021;9:1415. [PMID: 34209064 DOI: 10.3390/microorganisms9071415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
38 Marrazzo P, Pizzuti V, Zia S, Sargenti A, Gazzola D, Roda B, Bonsi L, Alviano F. Microfluidic Tools for Enhanced Characterization of Therapeutic Stem Cells and Prediction of Their Potential Antimicrobial Secretome. Antibiotics (Basel) 2021;10:750. [PMID: 34206190 DOI: 10.3390/antibiotics10070750] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
39 Ghosh SK, Weinberg A. Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2. Front Mol Biosci 2021;8:620806. [PMID: 34235176 DOI: 10.3389/fmolb.2021.620806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
40 Sharma S, Jeyaraman M, Muthu S, Anudeep TC, Jeyaraman N, Shringeri AS, Kumar V, Somasundaram R, Jain R, Jha SK. A Step Toward Optimizing Regenerative Medicine Principle to Combat COVID-19. Ann Natl Acad Med Sci 2021;57:202-13. [DOI: 10.1055/s-0041-1731597] [Reference Citation Analysis]
41 Brown HL, Clayton A, Stephens P. The role of bacterial extracellular vesicles in chronic wound infections: Current knowledge and future challenges. Wound Repair Regen 2021. [PMID: 34132443 DOI: 10.1111/wrr.12949] [Reference Citation Analysis]
42 Mckinnirey F, Herbert B, Vesey G, McCracken S. Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro. Sci Rep 2021;11:12454. [PMID: 34127731 DOI: 10.1038/s41598-021-91870-4] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
43 Pierce LM, Kurata WE. Priming With Toll-Like Receptor 3 Agonist Poly(I:C) Enhances Content of Innate Immune Defense Proteins but Not MicroRNAs in Human Mesenchymal Stem Cell-Derived Extracellular Vesicles. Front Cell Dev Biol 2021;9:676356. [PMID: 34109180 DOI: 10.3389/fcell.2021.676356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
44 Jahan D, Peile E, Sheikh MA, Islam S, Parasnath S, Sharma P, Iskandar K, Dhingra S, Charan J, Hardcastle TC, Samad N, Chowdhury TS, Dutta S, Haque M. Is it time to reconsider prophylactic antimicrobial use for hematopoietic stem cell transplantation? a narrative review of antimicrobials in stem cell transplantation. Expert Rev Anti Infect Ther 2021;:1-22. [PMID: 33711240 DOI: 10.1080/14787210.2021.1902304] [Reference Citation Analysis]
45 Ye G, Wang P, Xie Z, Cao Q, Li J, Zheng G, Wang S, Li M, Liu W, Cen S, Li Z, Yu W, Wu Y, Shen H. Autophagy-Mediated Activation of Mucosal-Associated Invariant T Cells Driven by Mesenchymal Stem Cell-Derived IL-15. Stem Cell Reports 2021;16:926-39. [PMID: 33798448 DOI: 10.1016/j.stemcr.2021.03.005] [Reference Citation Analysis]
46 Fernández-Francos S, Eiro N, Costa LA, Escudero-Cernuda S, Fernández-Sánchez ML, Vizoso FJ. Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine. Int J Mol Sci 2021;22:3576. [PMID: 33808241 DOI: 10.3390/ijms22073576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
47 Ghigo A, Prono G, Riccardi E, De Rose V. Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches. Int J Mol Sci 2021;22:1952. [PMID: 33669352 DOI: 10.3390/ijms22041952] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Musial C, Gorska-Ponikowska M. Medical progress: Stem cells as a new therapeutic strategy for COVID-19. Stem Cell Res 2021;52:102239. [PMID: 33601098 DOI: 10.1016/j.scr.2021.102239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Sanchez-Castro EE, Pajuelo-Reyes C, Tejedo R, Soria-Juan B, Tapia-Limonchi R, Andreu E, Hitos AB, Martin F, Cahuana GM, Guerra-Duarte C, de Assis TCS, Bedoya FJ, Soria B, Chávez-Olórtegui C, Tejedo JR. Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming. Front Immunol 2020;11:609961. [PMID: 33633730 DOI: 10.3389/fimmu.2020.609961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Melotti L, Martinello T, Perazzi A, Martines E, Zuin M, Modenese D, Cordaro L, Ferro S, Maccatrozzo L, Iacopetti I, Patruno M. Could cold plasma act synergistically with allogeneic mesenchymal stem cells to improve wound skin regeneration in a large size animal model? Res Vet Sci 2021;136:97-110. [PMID: 33596495 DOI: 10.1016/j.rvsc.2021.01.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
51 Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, Nina PB, Jp D, Kumar S, Singh B, Tiwari RR. Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review. Front Microbiol 2021;12:609459. [PMID: 33574807 DOI: 10.3389/fmicb.2021.609459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
52 Chen K, Yoshimura T, Yao X, Gong W, Huang J, Dzutsev AK, McCulloch J, O'hUigin C, Bian XW, Trinchieri G, Wang JM. Distinct contributions of cathelin-related antimicrobial peptide (CRAMP) derived from epithelial cells and macrophages to colon mucosal homeostasis. J Pathol 2021;253:339-50. [PMID: 33104252 DOI: 10.1002/path.5572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Papait A, Cargnoni A, Sheleg M, Silini AR, Kunis G, Ofir R, Parolini O. Perinatal Cells: A Promising COVID-19 Therapy? Front Bioeng Biotechnol 2020;8:619980. [PMID: 33520970 DOI: 10.3389/fbioe.2020.619980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Zhang L, Ghosh SK, Basavarajappa SC, Muller-Greven J, Penfield J, Brewer A, Ramakrishnan P, Buck M, Weinberg A. Molecular dynamics simulations and functional studies reveal that hBD-2 binds SARS-CoV-2 spike RBD and blocks viral entry into ACE2 expressing cells. bioRxiv 2021:2021. [PMID: 33442698 DOI: 10.1101/2021.01.07.425621] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
55 Mazini L, Ezzoubi M, Malka G. Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19. Stem Cell Res Ther 2021;12:1. [PMID: 33397467 DOI: 10.1186/s13287-020-02006-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 43] [Article Influence: 13.0] [Reference Citation Analysis]
56 Kwon S, Shin S, Do M, Oh BH, Song Y, Bui VD, Lee ES, Jo DG, Cho YW, Kim DH, Park JH. Engineering approaches for effective therapeutic applications based on extracellular vesicles. J Control Release 2021;330:15-30. [PMID: 33278480 DOI: 10.1016/j.jconrel.2020.11.062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
57 Russell KA, Garbin LC, Wong JM, Koch TG. Mesenchymal Stromal Cells as Potential Antimicrobial for Veterinary Use-A Comprehensive Review. Front Microbiol 2020;11:606404. [PMID: 33335522 DOI: 10.3389/fmicb.2020.606404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
58 Vázquez A, Fernández-Sevilla LM, Jiménez E, Pérez-Cabrera D, Yañez R, Subiza JL, Varas A, Valencia J, Vicente A. Involvement of Mesenchymal Stem Cells in Oral Mucosal Bacterial Immunotherapy. Front Immunol 2020;11:567391. [PMID: 33329530 DOI: 10.3389/fimmu.2020.567391] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
59 Shetty R, Murugeswari P, Chakrabarty K, Jayadev C, Matalia H, Ghosh A, Das D. Stem cell therapy in coronavirus disease 2019: current evidence and future potential. Cytotherapy 2021;23:471-82. [PMID: 33257213 DOI: 10.1016/j.jcyt.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Yao D, Ye H, Huo Z, Wu L, Wei S. Mesenchymal stem cell research progress for the treatment of COVID-19. J Int Med Res. 2020;48:300060520955063. [PMID: 32972277 DOI: 10.1177/0300060520955063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
61 Radmanesh F, Mahmoudi M, Yazdanpanah E, Keyvani V, Kia N, Nikpoor AR, Zafari P, Esmaeili SA. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus. IUBMB Life 2020;72:2366-81. [PMID: 33006813 DOI: 10.1002/iub.2387] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
62 Gentile P, Sterodimas A, Pizzicannella J, Calabrese C, Garcovich S. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease. Aging Dis 2020;11:1191-201. [PMID: 33014532 DOI: 10.14336/AD.2020.0711] [Cited by in Crossref: 17] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
63 Kassem DH, Kamal MM. Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis. Front Cell Dev Biol 2020;8:587866. [PMID: 33102489 DOI: 10.3389/fcell.2020.587866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
64 Najar M, Martel-Pelletier J, Pelletier JP, Fahmi H. Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis. Front Cell Dev Biol 2020;8:567813. [PMID: 33072752 DOI: 10.3389/fcell.2020.567813] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
65 Dubus M, Varin-Simon J, Prada P, Scomazzon L, Reffuveille F, Alem H, Boulmedais F, Mauprivez C, Rammal H, Kerdjoudj H. Biopolymers-calcium phosphate antibacterial coating reduces the pathogenicity of internalized bacteria by mesenchymal stromal cells. Biomater Sci 2020;8:5763-73. [PMID: 32945302 DOI: 10.1039/d0bm00962h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
66 Samaddar A, Grover M, Nag VL. Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly Understood Arena. Front Pharmacol. 2020;11:585888. [PMID: 33041830 DOI: 10.3389/fphar.2020.585888] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
67 Zengin R, Beyaz O, Koc ES, Akinci IO, Kocagoz S, Sagcan G, Ovali E, Cuhadaroglu C. Mesenchymal stem cell treatment in a critically ill COVID-19 patient: a case report.Stem Cell Investig. 2020;7:17. [PMID: 33110915 DOI: 10.21037/sci-2020-024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
68 Masterson CH, McCarthy SD, O'Toole D, Laffey JG. The role of cells and their products in respiratory drug delivery: the past, present, and future. Expert Opin Drug Deliv 2020;17:1689-702. [PMID: 32842784 DOI: 10.1080/17425247.2020.1814732] [Reference Citation Analysis]
69 Khosrojerdi A, Soudi S, Hosseini AZ, Eshghi F, Shafiee A, Hashemi SM. Immunomodulatory and Therapeutic Effects of Mesenchymal Stem Cells on Organ Dysfunction in Sepsis. Shock 2021;55:423-40. [PMID: 32826813 DOI: 10.1097/SHK.0000000000001644] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Byrnes D, Masterson CH, Artigas A, Laffey JG. Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome. Semin Respir Crit Care Med 2021;42:20-39. [PMID: 32767301 DOI: 10.1055/s-0040-1713422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
71 Costa LA, Eiro N, Fraile M, Gonzalez LO, Saá J, Garcia-Portabella P, Vega B, Schneider J, Vizoso FJ. Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses.Cell Mol Life Sci. 2021;78:447-467. [PMID: 32699947 DOI: 10.1007/s00018-020-03600-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 62] [Article Influence: 11.5] [Reference Citation Analysis]
72 Yagi H, Chen AF, Hirsch D, Rothenberg AC, Tan J, Alexander PG, Tuan RS. Antimicrobial activity of mesenchymal stem cells against Staphylococcus aureus. Stem Cell Res Ther 2020;11:293. [PMID: 32680544 DOI: 10.1186/s13287-020-01807-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
73 Singh VK, Mishra A, Singh S, Kumar P, Singh M, Jagannath C, Khan A. Emerging Prevention and Treatment Strategies to Control COVID-19. Pathogens 2020;9:E501. [PMID: 32585805 DOI: 10.3390/pathogens9060501] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
74 Cushnie TPT, Cushnie B, Echeverría J, Fowsantear W, Thammawat S, Dodgson JLA, Law S, Clow SM. Bioprospecting for Antibacterial Drugs: a Multidisciplinary Perspective on Natural Product Source Material, Bioassay Selection and Avoidable Pitfalls. Pharm Res 2020;37:125. [PMID: 32529587 DOI: 10.1007/s11095-020-02849-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
75 Hosseiniyan Khatibi SM, Kheyrolahzadeh K, Barzegari A, Rahbar Saadat Y, Zununi Vahed S. Medicinal signaling cells: A potential antimicrobial drug store. J Cell Physiol 2020;235:7731-46. [PMID: 32352173 DOI: 10.1002/jcp.29728] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
76 Cheng Y, Cao X, Qin L. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy for Sepsis. Front Immunol 2020;11:647. [PMID: 32373121 DOI: 10.3389/fimmu.2020.00647] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
77 Abusrewil S, Alshanta OA, Albashaireh K, Alqahtani S, Nile CJ, Scott JA, McLean W. Detection, treatment and prevention of endodontic biofilm infections: what's new in 2020? Crit Rev Microbiol 2020;46:194-212. [PMID: 32233822 DOI: 10.1080/1040841X.2020.1739622] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
78 Marx C, Gardner S, Harman RM, Van de Walle GR. The mesenchymal stromal cell secretome impairs methicillin-resistant Staphylococcus aureus biofilms via cysteine protease activity in the equine model. Stem Cells Transl Med 2020;9:746-57. [PMID: 32216094 DOI: 10.1002/sctm.19-0333] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
79 Çankirili NK, Kart D, Çelebi-saltik B. Evaluation of the biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa on human umbilical cord CD146+ stem cells and stem cell-based decellularized matrix. Cell Tissue Bank 2020;21:215-31. [DOI: 10.1007/s10561-020-09815-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Sava RI, Pepine CJ, March KL. Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy. J Clin Med 2020;9:E241. [PMID: 31963368 DOI: 10.3390/jcm9010241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
81 Mayo JS, Kurata WE, O'Connor KM, Pierce LM. Oxidative Stress Alters Angiogenic and Antimicrobial Content of Extracellular Vesicles and Improves Flap Survival. Plast Reconstr Surg Glob Open 2019;7:e2588. [PMID: 32537316 DOI: 10.1097/GOX.0000000000002588] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
82 Laroye C, Gauthier M, Antonot H, Decot V, Reppel L, Bensoussan D. Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton's Jelly, an Extraembryonic Source. J Clin Med 2019;8:E2207. [PMID: 31847319 DOI: 10.3390/jcm8122207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
83 McCarthy SD, Horgan E, Ali A, Masterson C, Laffey JG, MacLoughlin R, O'Toole D. Nebulized Mesenchymal Stem Cell Derived Conditioned Medium Retains Antibacterial Properties Against Clinical Pathogen Isolates. J Aerosol Med Pulm Drug Deliv 2020;33:140-52. [PMID: 31730399 DOI: 10.1089/jamp.2019.1542] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
84 Bahroudi M, Bakhshi B, Soudi S, Najar-Peerayeh S. Antibacterial and antibiofilm activity of bone marrow-derived human mesenchymal stem cells secretome against Vibrio cholerae. Microb Pathog 2020;139:103867. [PMID: 31712121 DOI: 10.1016/j.micpath.2019.103867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
85 Chow L, Johnson V, Impastato R, Coy J, Strumpf A, Dow S. Antibacterial activity of human mesenchymal stem cells mediated directly by constitutively secreted factors and indirectly by activation of innate immune effector cells. Stem Cells Transl Med 2020;9:235-49. [PMID: 31702119 DOI: 10.1002/sctm.19-0092] [Cited by in Crossref: 27] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
86 Monsarrat P, Kémoun P, Casteilla L, Planat-Bénard V. Broad-Spectrum Antibacterial Effects of Human Adipose-Derived Stromal Cells. Stem Cells Int 2019;2019:5389629. [PMID: 31781241 DOI: 10.1155/2019/5389629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
87 Esfandiyari R, Halabian R, Behzadi E, Sedighian H, Jafari R, Imani Fooladi AA. Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells. Heliyon 2019;5:e02652. [PMID: 31687504 DOI: 10.1016/j.heliyon.2019.e02652] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
88 Cruz FF, Rocco PRM. The potential of mesenchymal stem cell therapy for chronic lung disease. Expert Rev Respir Med. 2020;14:31-39. [PMID: 31608724 DOI: 10.1080/17476348.2020.1679628] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 14.0] [Reference Citation Analysis]
89 Zanganeh E, Soudi S, Zavaran Hosseini A, Khosrojerdi A. Repeated intravenous injection of adipose tissue derived mesenchymal stem cells enhances Th1 immune responses in Leishmania major-infected BALB/c mice. Immunol Lett. 2019;216:97-105. [PMID: 31622634 DOI: 10.1016/j.imlet.2019.10.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
90 Pelizzo G, Avanzini MA, Lenta E, Mantelli M, Croce S, Catenacci L, Acquafredda G, Ferraro AL, Giambanco C, D'amelio L, Giordano S, Re G, Zennaro F, Calcaterra V. Allogeneic mesenchymal stromal cells: Novel therapeutic option for mutated FLNA‐associated respiratory failure in the pediatric setting. Pediatr Pulmonol 2019;55:190-7. [DOI: 10.1002/ppul.24497] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
91 Khan RS, Newsome PN. A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells. Front Immunol 2019;10:1952. [PMID: 31555259 DOI: 10.3389/fimmu.2019.01952] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
92 Bari E, Ferrarotti I, Di Silvestre D, Grisoli P, Barzon V, Balderacchi A, Torre ML, Rossi R, Mauri P, Corsico AG, Perteghella S. Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration. Cells 2019;8:E965. [PMID: 31450843 DOI: 10.3390/cells8090965] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
93 Vizoso FJ, Eiro N, Costa L, Esparza P, Landin M, Diaz-Rodriguez P, Schneider J, Perez-Fernandez R. Mesenchymal Stem Cells in Homeostasis and Systemic Diseases: Hypothesis, Evidences, and Therapeutic Opportunities. Int J Mol Sci 2019;20:E3738. [PMID: 31370159 DOI: 10.3390/ijms20153738] [Cited by in Crossref: 23] [Cited by in F6Publishing: 36] [Article Influence: 7.7] [Reference Citation Analysis]
94 Bari E, Ferrarotti I, Torre ML, Corsico AG, Perteghella S. Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation. J Control Release. 2019;309:11-24. [PMID: 31326462 DOI: 10.1016/j.jconrel.2019.07.022] [Cited by in Crossref: 36] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
95 Florea V, Bagno L, Rieger AC, Hare JM. Attenuation of frailty in older adults with mesenchymal stem cells. Mechanisms of Ageing and Development 2019;181:47-58. [DOI: 10.1016/j.mad.2019.111120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
96 Laroye C, Boufenzer A, Jolly L, Cunat L, Alauzet C, Merlin JL, Yguel C, Bensoussan D, Reppel L, Gibot S. Bone marrow vs Wharton's jelly mesenchymal stem cells in experimental sepsis: a comparative study. Stem Cell Res Ther. 2019;10:192. [PMID: 31248453 DOI: 10.1186/s13287-019-1295-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
97 Li H, Zhang S, Nie B, Long T, Qu X, Yue B. KR-12-a5 Reverses Adverse Effects of Lipopolysaccharides on HBMSC Osteogenic Differentiation by Influencing BMP/Smad and P38 MAPK Signaling Pathways. Front Pharmacol 2019;10:639. [PMID: 31231225 DOI: 10.3389/fphar.2019.00639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
98 Kadam S, Shai S, Shahane A, Kaushik KS. Recent Advances in Non-Conventional Antimicrobial Approaches for Chronic Wound Biofilms: Have We Found the 'Chink in the Armor'? Biomedicines 2019;7:E35. [PMID: 31052335 DOI: 10.3390/biomedicines7020035] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]
99 Lasocka I, Jastrzębska E, Szulc-Dąbrowska L, Skibniewski M, Pasternak I, Kalbacova MH, Skibniewska EM. The effects of graphene and mesenchymal stem cells in cutaneous wound healing and their putative action mechanism. Int J Nanomedicine 2019;14:2281-99. [PMID: 31015759 DOI: 10.2147/IJN.S190928] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
100 O'rourke F, Kempf VAJ. Interaction of bacteria and stem cells in health and disease. FEMS Microbiology Reviews 2019;43:162-80. [DOI: 10.1093/femsre/fuz003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
101 Jones JM, DePaul MA, Gregory CR, Lang BT, Xie H, Zhu M, Rutten MJ, Mays RW, Busch SA, Pati S, Gregory KW. Multipotent Adult Progenitor Cells, but Not Tissue Inhibitor of Matrix Metalloproteinase-3, Increase Tissue Sparing and Reduce Urological Complications following Spinal Cord Injury. J Neurotrauma 2019;36:1416-27. [PMID: 30251917 DOI: 10.1089/neu.2018.5727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Schulman IH, Balkan W, Hare JM. Mesenchymal Stem Cell Therapy for Aging Frailty. Front Nutr. 2018;5:108. [PMID: 30498696 DOI: 10.3389/fnut.2018.00108] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
103 Franco AR, Palma Kimmerling E, Silva C, Rodrigues FJ, Leonor IB, Reis RL, Kaplan DL. Silk‐Based Antimicrobial Polymers as a New Platform to Design Drug‐Free Materials to Impede Microbial Infections. Macromol Biosci 2018;18:1800262. [DOI: 10.1002/mabi.201800262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
104 Laroye C, Lemarié J, Boufenzer A, Labroca P, Cunat L, Alauzet C, Groubatch F, Cailac C, Jolly L, Bensoussan D, Reppel L, Gibot S. Clinical-grade mesenchymal stem cells derived from umbilical cord improve septic shock in pigs. Intensive Care Med Exp 2018;6:24. [PMID: 30091119 DOI: 10.1186/s40635-018-0194-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
105 Magne B, Lataillade JJ, Trouillas M. Mesenchymal Stromal Cell Preconditioning: The Next Step Toward a Customized Treatment For Severe Burn. Stem Cells Dev 2018;27:1385-405. [PMID: 30039742 DOI: 10.1089/scd.2018.0094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
106 Roesch EA, Nichols DP, Chmiel JF. Inflammation in cystic fibrosis: An update. Pediatr Pulmonol 2018;53:S30-50. [DOI: 10.1002/ppul.24129] [Cited by in Crossref: 91] [Cited by in F6Publishing: 98] [Article Influence: 22.8] [Reference Citation Analysis]
107 Venkat P, Chen J, Chopp M. Exosome-mediated amplification of endogenous brain repair mechanisms and brain and systemic organ interaction in modulating neurological outcome after stroke. J Cereb Blood Flow Metab 2018;38:2165-78. [PMID: 29888985 DOI: 10.1177/0271678X18782789] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
108 Silva ON, Porto WF, Ribeiro SM, Batista I, Franco OL. Host-defense peptides and their potential use as biomarkers in human diseases. Drug Discov Today 2018;23:1666-71. [PMID: 29803935 DOI: 10.1016/j.drudis.2018.05.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
109 Cuenca J, Le-Gatt A, Castillo V, Belletti J, Díaz M, Kurte G M, Gonzalez PL, Alcayaga-Miranda F, Schuh CMAP, Ezquer F, Ezquer M, Khoury M. The Reparative Abilities of Menstrual Stem Cells Modulate the Wound Matrix Signals and Improve Cutaneous Regeneration. Front Physiol 2018;9:464. [PMID: 29867527 DOI: 10.3389/fphys.2018.00464] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
110 Broekman W, Khedoe PPSJ, Schepers K, Roelofs H, Stolk J, Hiemstra PS. Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease? Thorax 2018;73:565-74. [PMID: 29653970 DOI: 10.1136/thoraxjnl-2017-210672] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 11.5] [Reference Citation Analysis]
111 Khoury O, Barrios C, Ortega V, Atala A, Murphy SV. Immunomodulatory Cell Therapy to Target Cystic Fibrosis Inflammation. Am J Respir Cell Mol Biol 2018;58:12-20. [PMID: 28707978 DOI: 10.1165/rcmb.2017-0160TR] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
112 Gotts JE, Matthay MA. Cell-based Therapy in Sepsis. A Step Closer. Am J Respir Crit Care Med 2018;197:280-1. [DOI: 10.1164/rccm.201710-2068ed] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
113 Li H, Zhang S, Nie B, Du Z, Long T, Yue B. The antimicrobial peptide KR-12 promotes the osteogenic differentiation of human bone marrow stem cells by stimulating BMP/SMAD signaling. RSC Adv 2018;8:15547-57. [DOI: 10.1039/c8ra00750k] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
114 Mushahary D, Spittler A, Kasper C, Weber V, Charwat V. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A. 2018;93:19-31. [PMID: 29072818 DOI: 10.1002/cyto.a.23242] [Cited by in Crossref: 140] [Cited by in F6Publishing: 182] [Article Influence: 28.0] [Reference Citation Analysis]
115 Cruz FF, Rocco PRM. Stem-cell extracellular vesicles and lung repair. Stem Cell Investig 2017;4:78. [PMID: 29057250 DOI: 10.21037/sci.2017.09.02] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
116 Johnson V, Webb T, Norman A, Coy J, Kurihara J, Regan D, Dow S. Activated Mesenchymal Stem Cells Interact with Antibiotics and Host Innate Immune Responses to Control Chronic Bacterial Infections. Sci Rep 2017;7:9575. [PMID: 28851894 DOI: 10.1038/s41598-017-08311-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]